Relationship of PPARG overexpression with prognostic parameters in papillary thyroid carcinoma
Authors:
Open Access
- 1 February 2022
- journal article
- research article
- Published by Pacini Editore in Acta Otorhinolaryngologica Italica
- Vol. 42 (1) , 34-40
Abstract
Objectives. PAX8/PPARG chromosomal rearrangement is frequently seen in thyroid cancer, and PPARG overexpression has been shown in the follicular variant of papillary thyroid carcinoma, but not in papillary thyroid carcinoma other than the follicular variant. The main aim of this study was to investigate the frequency of PPARG overexpression among papillary thyroid carcinoma and if there were any variants of papillary thyroid carcinoma with PPARG overexpression other than the follicular variant. Methods. Immunohistochemical analysis of PPARG overexpression was performed using a PPARG monoclonal antibody in a series of 111 paraffin-embedded blocks of thyroid tumours. Of the patients in our study, 100 were diagnosed with papillary thyroid carcinoma, 9 with follicular adenoma and 2 with follicular carcinoma. Results. PPARG staining was detected in 19 of the 111 cases. Sixteen patients with PPARG overexpression had papillary thyroid carcinoma and 3 had follicular adenoma. Conclusions. PPARG overexpression was detected mainly in follicular-variant papillary thyroid carcinoma. Vascular invasion, lymphatic invasion, thyroid capsule invasion and lymph node positivity were lower in patients with PPARG overexpression.Keywords
This publication has 22 references indexed in Scilit:
- Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive IodineThe Journal of Clinical Endocrinology & Metabolism, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Pax-8–PPAR-γ fusion protein in thyroid carcinomaNature Reviews Endocrinology, 2014
- Pioglitazone Induces a Proadipogenic Antitumor Response in Mice with PAX8-PPARγ Fusion Protein Thyroid CarcinomaEndocrinology, 2011
- Thyroid Cancer Epidemiology and Prognostic VariablesClinical Oncology, 2010
- MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer CellsCancer Research, 2007
- A Subset of the Follicular Variant of Papillary Thyroid Carcinoma Harbors the PAX8-PPARγ TranslocationInternational Journal of Surgical Pathology, 2005
- Follicular variant of papillary thyroid carcinoma: Genome‐wide appraisal of a controversial entityGenes, Chromosomes and Cancer, 2004
- PAX8-PPARγ Rearrangement in Thyroid TumorsAmerican Journal of Surgical Pathology, 2002
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995